News and Media : 2011 :

Gustavo Fernandez, M.D., the study’s principal investigator, readies patient Robert Chambers for his last dose of the promising drug.

Out of Options, First Patient in Bladder Cancer Trial Now Has Hope

When Robert Chambers became the first patient to receive a potential new bladder cancer therapy developed by Miller School Nobel laureate Andrew V. Schally, he was out of treatment options, and hope. But after his final dose of the promising drug, Chambers is feeling better.

Read more »